Avalon Investment & Advisory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Avalon Investment & Advisory's BIIB Position: Q3 2021 in Review
Avalon Investment & Advisory sold out of Biogen (BIIB) in Q3 2021, closing a stake of 1,239 shares — an estimated $429K sold.
Avalon Investment & Advisory first reported a position in BIIB in Q2 2013 and held it in 14 quarters. The position peaked at $10.8M in Q3 2018. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.
- Avalon Investment & Advisory reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
- Avalon Investment & Advisory sold 1,239 Biogen shares in Q3 2021, an estimated $429K.
- Avalon Investment & Advisory first reported a position in Biogen in Q2 2013 and held it in 14 quarters.
- Avalon Investment & Advisory's Biogen position peaked at $10.8M in Q3 2018.
- 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.
Based on Avalon Investment & Advisory's 13F filing for Q3 2021, filed 8 Nov 2021.